| Literature DB >> 27737629 |
L Antonio González-Grajales1, Laura A Favetta1, W Allan King1, Gabriela F Mastromonaco2,3.
Abstract
BACKGROUND: Successful development of iSCNT (interspecies somatic cell nuclear transfer) embryos depends on complex interactions between ooplasmic and nuclear components, which can be compromised by genetic divergence. Transfer of ooplasm matching the genetic background of the somatic cell in iSCNT embryos is a valuable tool to study the degree of incompatibilities between nuclear and ooplasmic components. This study investigated the effects of ooplasm transfer (OT) on cattle (Bos taurus) and plains bison (Bison bison bison) embryos produced by iSCNT and supplemented with or without ooplasm from cattle or plains bison oocytes.Entities:
Keywords: ATP; Gene expression; Micromanipulation techniques; Mitochondria
Mesh:
Substances:
Year: 2016 PMID: 27737629 PMCID: PMC5064788 DOI: 10.1186/s12861-016-0137-6
Source DB: PubMed Journal: BMC Dev Biol ISSN: 1471-213X Impact factor: 1.978
Fig. 1Representation of iSCNT and OT procedures. a Large blue and yellow circles represent plains bison and cattle oocytes, respectively. Red diamonds denote a nucleus. b A portion of plains bison ooplasm (small blue circle) and plains bison somatic cell (small brown circle) are introduced in the perivitelline space. c Reconstructed embryos + OT after first electropulse (scattered blue pattern). d Reconstructed embryo after second electro pulse showing successful fusion of the somatic cell
Fig. 2Phase contrast micrographs of oocytes following ooplasm and somatic cell transfer. a cattle oocyte + cattle ooplasm and somatic donor cell nucleus, arrow represents the cattle somatic cell while the arrow head denotes the portion of ooplasm being transferred into the perivitelline space; b a different oocyte taken 5 min after first DC pulse. Note fusion process between the cattle oocyte and the portion of cattle ooplasm (arrow head) with presence of the somatic cell in the back (thin arrow)
List of primers used for qPCR experiments
| Gene | Genbank accession number | Primer sequence | Product size (bp) | Reference |
|---|---|---|---|---|
| GAPDH | NM_001034034.2 | F: 5′-ttcctggtacgacaatgaatt-3′ | 131 | [ |
| mt-COX2 | 3283880 | F: 5′-attctgcccgccatcatc-3′ | 203 | [ |
| TFAM | NM_001034016.2 | F: 5′-ccgaaaagacctcgctca-3′ | 221 | [ |
| NRF2 | AB162435 | F: 5′-tccaacctttgtcgtcatca-3′ | 174 | [ |
Percentage of reconstructed embryos developed to the 2, 4, and 8–16 cell stage
| Stage of development | C [ | C+ OT [ | PB [ | PB + OT [ |
|
|---|---|---|---|---|---|
| 2-cell stagea | 91.7 ± 4.0 | 87.5 ± 2.4 | 88.2 ± 3.5 | 88.0 ± 2.4 | 0.81 |
| 4-cell stagea | 83.5 ± 2.5 | 80.0 ± 4.9 | 80.0 ± 6.8 | 76.0 ± 4.9 | 0.76 |
| 8–16 cell stagea | 57.6 ± 4.7 | 61.2 ± 8.1 | 60.0 ± 7.3 | 58.0 ± 7.4 | 0.96 |
avalues are reported as mean ± SEM
Fig. 3ATP quantification in reconstructed embryos at 8–16 cell stage with or without OT
Fig. 4Gene expression profiles of mt-COX-2 (a), NRF-2 (b), and TFAM (c) in IVF and reconstructed embryos at the 8–16 cell stage